R26-CAG-EGFP(3)

Nomenclature

C57BL/6Smoc-Gt(ROSA)26Sorem2(CAG-EGFP-WPRE-polyA)Smoc

Cat. NO.

NM-KI-190090

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Gt(ROSA)26Sor

Synonyms

R26，ROSA26，AV258896，Gtrgeo26，Gtrosa26，Thumpd3as1

NCBI ID

14910

MGI ID

104735

Ensembl ID

ENSMUSG00000086429

Pubmed

Gt(ROSA)26Sor

Model Description

These mice harbor a CAG-EGFP-WPRE-polyA cassette in the Rosa26 locus.2 generated by homologous recombination. While R26-CAG-EGFP(Stock No.NM-KI-190088) and R26-CAG-EGFP(2)(Stock No.NM-KI-190089) function similarly to R26-CAG-EGFP(3) mice,for more detailed information please contact our technical advisor.
Research Application：Reporter mice,EGFP

Validation Data

NM-kl-190090 R26-CAG-EGFP(1).jpg

Fig 1. Detection of EGFP (Green) in various tissues of R26-CAG-EGFP(3) mice. Expression tissues include: brain, eyes, heart, lungs, liver, stomach, salivary glands, adrenal glands, kidneys, colon, small intestine, spleen, pancreas, uterus and ovaries, skin, thymus, pituitary gland. A few cells expressed in spinal cord and brown fat. (37-week old and 10.3-week old, female) (For more detailed information please contact our technical advisor.) 

image.png

Fig2. Comparison of EGFP expression in live CD45+ Leukocytes cells in blood and live cells in various organs.


image.png

Fig3. Comparison of EGFP expression across Immune Cell subsets in PB, bone marrow, spleen and thymus.

Publications 1piece

1. CCL2-mediated inflammatory pathogenesis underlies high myopia-related anxiety
Published year：2023-09-12 References：Cell Discovery

展开

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more